Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.003 | 1 |
mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.0079 | 1 |
mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |